Invasive aspergillosis in patients with solid tumors
Open Access
- 27 September 2004
- Vol. 101 (10) , 2300-2302
- https://doi.org/10.1002/cncr.20647
Abstract
Invasive aspergillosis (IA) has been reported only rarely among patients with solid tumors. In the current study, the authors retrospectively identified 13 episodes of definite or probable IA (using European Organization for Research and Treatment of Cancer criteria) occurring in patients with solid tumors who were treated between 1994–2003. Nine patients had pulmonary IA and three patients were found to have IA of the brain. Seven patients (54%) had primary or metastatic brain tumors and 6 patients (46%) received systemic steroids within 30 days prior to the diagnosis of IA. The majority of patients (69%) had a lymphocyte count < 500/μL but only 1 patient was neutropenic within the 30 days before the diagnosis of IA was made. Nodular infiltrates and cavities were the most common radiologic findings. Seven patients (54%) responded to antifungal treatment. Cancer 2004. © 2004 American Cancer Society.Keywords
This publication has 6 references indexed in Scilit:
- The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancerCancer, 2003
- Glucocorticoids and invasive fungal infectionsThe Lancet, 2003
- Invasive Aspergillosis in 2002: An UpdateEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusClinical Infectious Diseases, 2002
- Invasive Aspergillosis Disease Spectrum, Treatment Practices, and OutcomesMedicine, 2000
- Trends in the postmortem epidemiology of invasive fungal infections at a University HospitalJournal of Infection, 1996